COVID-19 and diabetes: Is metformin a friend or foe?
Francesco Ursini, Jacopo Ciaffi, Maria Paola Landini, Riccardo Melicòni
Topics & Concepts
MedicineDiabetes mellitusMetforminScopusCoronavirus disease 2019 (COVID-19)Angiotensin Receptor BlockersPandemicPopulationDiseaseEpidemiologyInternal medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEType 2 diabetesAngiotensin-converting enzymeEndocrinologyInfectious disease (medical specialty)Blood pressureLawEnvironmental healthPolitical scienceCOVID-19 Clinical Research StudiesMetabolism, Diabetes, and CancerPARP inhibition in cancer therapy